Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 1999

Study Completion Date

April 30, 2001

Conditions
HIV Infections
Interventions
DRUG

Abacavir sulfate

Trial Locations (30)

10003

Beth Israel Med Ctr, New York

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10021

Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ, New York

10032

Columbia Presbyterian Med Ctr, New York

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

14642

Univ of Rochester Medical Center, Rochester

19104

Philadelphia Veterans Administration Med Ctr, Philadelphia

Univ of Pennsylvania at Philadelphia, Philadelphia

21287

Johns Hopkins Hosp, Baltimore

27710

Duke Univ Med Ctr, Durham

29169

Julio Arroyo, West Columbia

30308

Emory Univ, Atlanta

37203

Vanderbilt Univ Med Ctr, Nashville

60611

Northwestern Univ Med School, Chicago

60612

Cook County Hosp, Chicago

63112

St Louis Regional Hosp / St Louis Regional Med Ctr, St Louis

75390

Univ of Texas, Southwestern Med Ctr of Dallas, Dallas

80262

Univ of Colorado Health Sciences Ctr, Denver

90095

UCLA CARE Ctr, Los Angeles

90502

Harbor UCLA Med Ctr, Torrance

94025

Willow Clinic, Menlo Park

98104

Univ of Washington, Seattle

212052196

State of MD Div of Corrections / Johns Hopkins Univ Hosp, Baltimore

275997215

Univ of North Carolina, Chapel Hill

331361013

Univ of Miami School of Medicine, Miami

452670405

Univ of Cincinnati, Cincinnati

943055107

San Mateo AIDS Program / Stanford Univ, Stanford

Stanford Univ Med Ctr, Stanford

951282699

Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium, San Jose

009365067

Univ of Puerto Rico, San Juan

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH